HOOKIPA Pharma
HOOKIPA Pharma was a New York- and Vienna-based clinical-stage biopharmaceutical company that developed arenavirus-vector immunotherapies. After selling its infectious-disease and oncology assets, shareholders approved liquidation and the company was dissolved in 2026.
Key facts
| Business Model | Commerce |
|---|---|
| Full Address | Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria |
| Stock Symbol | HOOK |
| Wellfound ID | hookipa-biotech |
Contact details
Email and phone for HOOKIPA Pharma are available to signed-in members of CliffBio.
Sign in to view